MMJ's CEO Jason Conroy commented that "We are pleased that Bien has withdrawn its resources from test marketing in California and turned its focus to developing proprietary IP at a time when a number of Canadian Licensed Producers are actively looking for development partners, particularly in the cannabis edibles segment."
MMJ owns 13.7% of Bien.
To view the media release, please visit:
About MMJ PhytoTech Ltd
MMJ PhytoTech Limited (ASX:MMJ) is a global cannabis investment company. MMJ owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, technology, infrastructure, logistics, processing, cultivation, equipment and retail. For MMJ's latest investor presentation and news, please visit: http://www.mmjphytotech.com.au/investors/
ContactInvestor and Media Enquiries:
Chief Executive Officer